ID

20222

Descripción

Study With AG-013736 Combined With Chemotherapy And Bevacizumab In Patients With Metastatic Colorectal Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00460603

Link

https://clinicaltrials.gov/show/NCT00460603

Palabras clave

Versiones (1)
  1. 14/2/17 14/2/17 -
Subido en

14 de febrero de 2017

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Colorectal Neoplasms NCT00460603

Inglés

Eligibility Colorectal Neoplasms NCT00460603

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
(phase 1) patients with any solid/gi tumor who have had no more than 1 previous chemotherapy for greater than 3 months prior to enrollment
Descripción

Gastrointestinal Neoplasm Solid | Chemotherapy Quantity

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0017185
UMLS CUI [1,2]
C0205208
UMLS CUI [2,1]
C0392920
UMLS CUI [2,2]
C1265611
(phase 2) patients with locally advanced or metastatic colorectal cancer (crc) previously untreated with any systemic therapy.
Descripción

Colorectal Carcinoma Advanced Local | Colorectal cancer metastatic | Systemic therapy Absent

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0009402
UMLS CUI [1,2]
C0205179
UMLS CUI [1,3]
C0205276
UMLS CUI [2]
C0948380
UMLS CUI [3,1]
C1515119
UMLS CUI [3,2]
C0332197
patients treated with adjuvant chemotherapy (with radiation) will be eligible if last treatment was > 12 months prior to enrollment,
Descripción

Chemotherapy, Adjuvant | Therapeutic radiology procedure

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0085533
UMLS CUI [2]
C1522449
patients must have measurable disease by recist and if any history of hypertension, it must be controlled with medication.
Descripción

Measurable Disease | Hypertensive disease Controlled by Pharmaceutical Preparations

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1513041
UMLS CUI [2,1]
C0020538
UMLS CUI [2,2]
C0332298
UMLS CUI [2,3]
C0013227
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
prior system therapy for advanced crc (ph 2 portion only)
Descripción

Systemic therapy Colorectal Carcinoma Advanced

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1515119
UMLS CUI [1,2]
C0009402
UMLS CUI [1,3]
C0205179
prior treatment with anti-angiogenesis agent such as bevacizumab or vegf inhibitors.
Descripción

Angiogenesis Inhibitors | bevacizumab | Vascular Endothelial Growth Factor Inhibitors

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0596087
UMLS CUI [2]
C0796392
UMLS CUI [3]
C2267120
prior irradiation of greater than 25% of bone marrow (whole pelvis = 25%)
Descripción

Therapeutic radiology procedure Bone Marrow Percentage | Therapeutic radiology procedure Whole-Pelvis Percentage

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1522449
UMLS CUI [1,2]
C0005953
UMLS CUI [1,3]
C0439165
UMLS CUI [2,1]
C1522449
UMLS CUI [2,2]
C3827467
UMLS CUI [2,3]
C0439165
prior radiation, major surgery, or investigational agent within 4 weeks of study entry except palliative radiotherapy to non-target, metastatic lesions. minor surgeries should be completed > 2 weeks of enrollment and be fully recovered from any procedure.
Descripción

Therapeutic radiology procedure | major surgery | Investigational New Drugs | Palliative course of radiotherapy Metastatic Lesion Non-Target | Minor Surgical Procedures Completed | Interventional procedure Recovered

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1522449
UMLS CUI [2]
C0679637
UMLS CUI [3]
C0013230
UMLS CUI [4,1]
C0475092
UMLS CUI [4,2]
C1513183
UMLS CUI [4,3]
C1518389
UMLS CUI [5,1]
C0038904
UMLS CUI [5,2]
C0205197
UMLS CUI [6,1]
C0184661
UMLS CUI [6,2]
C0521108
Volver a la parte superior de la página

Similar models

Eligibility Colorectal Neoplasms NCT00460603

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Gastrointestinal Neoplasm Solid | Chemotherapy Quantity
Item
(phase 1) patients with any solid/gi tumor who have had no more than 1 previous chemotherapy for greater than 3 months prior to enrollment
boolean
C0017185 (UMLS CUI [1,1])
C0205208 (UMLS CUI [1,2])
C0392920 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])
Colorectal Carcinoma Advanced Local | Colorectal cancer metastatic | Systemic therapy Absent
Item
(phase 2) patients with locally advanced or metastatic colorectal cancer (crc) previously untreated with any systemic therapy.
boolean
C0009402 (UMLS CUI [1,1])
C0205179 (UMLS CUI [1,2])
C0205276 (UMLS CUI [1,3])
C0948380 (UMLS CUI [2])
C1515119 (UMLS CUI [3,1])
C0332197 (UMLS CUI [3,2])
Chemotherapy, Adjuvant | Therapeutic radiology procedure
Item
patients treated with adjuvant chemotherapy (with radiation) will be eligible if last treatment was > 12 months prior to enrollment,
boolean
C0085533 (UMLS CUI [1])
C1522449 (UMLS CUI [2])
Measurable Disease | Hypertensive disease Controlled by Pharmaceutical Preparations
Item
patients must have measurable disease by recist and if any history of hypertension, it must be controlled with medication.
boolean
C1513041 (UMLS CUI [1])
C0020538 (UMLS CUI [2,1])
C0332298 (UMLS CUI [2,2])
C0013227 (UMLS CUI [2,3])
Item Group
C0680251 (UMLS CUI)
Systemic therapy Colorectal Carcinoma Advanced
Item
prior system therapy for advanced crc (ph 2 portion only)
boolean
C1515119 (UMLS CUI [1,1])
C0009402 (UMLS CUI [1,2])
C0205179 (UMLS CUI [1,3])
Angiogenesis Inhibitors | bevacizumab | Vascular Endothelial Growth Factor Inhibitors
Item
prior treatment with anti-angiogenesis agent such as bevacizumab or vegf inhibitors.
boolean
C0596087 (UMLS CUI [1])
C0796392 (UMLS CUI [2])
C2267120 (UMLS CUI [3])
Therapeutic radiology procedure Bone Marrow Percentage | Therapeutic radiology procedure Whole-Pelvis Percentage
Item
prior irradiation of greater than 25% of bone marrow (whole pelvis = 25%)
boolean
C1522449 (UMLS CUI [1,1])
C0005953 (UMLS CUI [1,2])
C0439165 (UMLS CUI [1,3])
C1522449 (UMLS CUI [2,1])
C3827467 (UMLS CUI [2,2])
C0439165 (UMLS CUI [2,3])
Therapeutic radiology procedure | major surgery | Investigational New Drugs | Palliative course of radiotherapy Metastatic Lesion Non-Target | Minor Surgical Procedures Completed | Interventional procedure Recovered
Item
prior radiation, major surgery, or investigational agent within 4 weeks of study entry except palliative radiotherapy to non-target, metastatic lesions. minor surgeries should be completed > 2 weeks of enrollment and be fully recovered from any procedure.
boolean
C1522449 (UMLS CUI [1])
C0679637 (UMLS CUI [2])
C0013230 (UMLS CUI [3])
C0475092 (UMLS CUI [4,1])
C1513183 (UMLS CUI [4,2])
C1518389 (UMLS CUI [4,3])
C0038904 (UMLS CUI [5,1])
C0205197 (UMLS CUI [5,2])
C0184661 (UMLS CUI [6,1])
C0521108 (UMLS CUI [6,2])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial